Skip to Content

Straumann Holding AG STMN

Morningstar Rating
CHF 136.00 +2.45 (1.83%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Straumann Wraps Up 2023 With Another Year of Share Gains and New Launches; Shares Still Expensive

Straumann is a global leader in dental implants, a market that is estimated to be worth CHF 5.2 billion. With over 60 years of experience, Straumann is frequently ranked as the most credible and trusted dental implant brand in the world. Today, the leading five companies hold about three quarters of the implant market with the remaining space shared among several hundred local players.

Price vs Fair Value

STMN is trading at a 37% premium.
Price
CHF 136.85
Fair Value
CHF 726.00
Uncertainty
Medium
1-Star Price
CHF 374.00
5-Star Price
CHF 99.00
Economic Moat
Tctkc
Capital Allocation
Szbhysnv

Bulls Say, Bears Say

Bulls

Straumann is making strategic acquisitions in high-growth markets.

Bears

Straumann might lose China market share because of volume-based procurement, which would have an adverse impact on more than half of sales in Asia-Pacific.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STMN is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 133.55
Day Range
CHF 134.75136.95
52-Week Range
CHF 97.00151.50
Bid/Ask
CHF 135.95 / CHF 136.05
Market Cap
CHF 21.68 Bil
Volume/Avg
46,335 / 214,028

Key Statistics

Price/Earnings (Normalized)
47.61
Price/Sales
9.07
Dividend Yield (Trailing)
0.64%
Dividend Yield (Forward)
0.64%
Total Yield
0.71%

Company Profile

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
11,100

Competitors

Valuation

Metric
STMN
ALGN
XRAY
Price/Earnings (Normalized)
47.6136.1016.86
Price/Book Value
11.906.421.94
Price/Sales
9.076.161.65
Price/Cash Flow
37.7929.9614.04
Price/Earnings
STMN
ALGN
XRAY

Financial Strength

Metric
STMN
ALGN
XRAY
Quick Ratio
1.340.980.76
Current Ratio
1.951.181.38
Interest Coverage
19.50−1.16
Quick Ratio
STMN
ALGN
XRAY

Profitability

Metric
STMN
ALGN
XRAY
Return on Assets (Normalized)
13.05%10.84%3.62%
Return on Equity (Normalized)
23.67%18.16%7.63%
Return on Invested Capital (Normalized)
18.17%17.22%5.75%
Return on Assets
STMN
ALGN
XRAY
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncByhkxmflwVqtw$133.8 Bil
BDX
Becton Dickinson & CoJbzfflthRtwhxn$67.6 Bil
ALC
Alcon IncLknscqhpJmdbpx$39.1 Bil
WST
West Pharmaceutical Services IncGcktlmybtmGgn$28.6 Bil
CLPBY
Coloplast A/S ADRBczvmkmhhyJsqz$27.9 Bil
RMD
ResMed IncTnjkdnvcLbjsjfs$27.0 Bil
BAX
Baxter International IncRznmrlfzCdlvn$20.9 Bil
COO
The Cooper Companies IncQbnbkkxvXcxbrdb$17.9 Bil
HOLX
Hologic IncXbcdmdwsDwjqwd$17.8 Bil
TFX
Teleflex IncPtxClsn$9.9 Bil

Sponsor Center